Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S H Chan

Showing results (451-460 of 458) with videos related to

Pageof 46
Sort By:
You have reached the last page of results.This site can display upto 458 results.
Frontiers in Immunology|August 22, 2013
Binding of Soluble Yeast β-Glucan to Human Neutrophils and Monocytes is Complement-DependentNandita Bose, Anissa S H Chan, Faimola Guerrero, et al.
Oncogene|March 11, 2014
MicroRNA-149 targets GIT1 to suppress integrin signaling and breast cancer metastasisS-H Chan, W-C Huang, J-W Chang, et al.
JAMA Oncology|December 29, 2022
Testing for EGFR Variants in Pleural and Pericardial Effusion Cell-Free DNA in Patients With Non-Small Cell Lung CancerKirsty W C Lee, Molly S C Li, Wanxia Gai, et al.
Cancer|December 23, 2014
Preliminary results of trial NPC-0501 evaluating the therapeutic gain by changing from concurrent-adjuvant to induction-concurrent chemoradiotherapy, changing from fluorouracil to capecitabine, and changing from conventional to accelerated radiotherapy fractionation in patients with locoregionally advanced nasopharyngeal carcinomaAnne W M Lee, Roger K C Ngan, Stewart Y Tung, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 8, 2025
Phase 2 trial of imprime and pembrolizumab immunotherapy in metastatic triple negative breast cancer patients who have progressed beyond first line chemotherapyAlison T Stopeck, Maysa Abu-Khalaf, Virginia Borges, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 17, 2019
Immune Pharmacodynamic Responses of the Novel Cancer Immunotherapeutic Imprime PGG in Healthy VolunteersNandita Bose, Nadine R Ottoson, Xiaohong Qiu, et al.
Nature Communications|January 9, 2021
Inhibiting Mycobacterium tuberculosis CoaBC by targeting an allosteric siteVitor Mendes, Simon R Green, Joanna C Evans, et al.
Tissue Antigens|July 6, 2007
Relative predispositional effects of HLA class II DRB1-DQB1 haplotypes and genotypes on type 1 diabetes: a meta-analysisG Thomson, A M Valdes, J A Noble, et al.
Pageof 46

Showing results (451-460 of 458) with videos related to

Sort By:
Pageof 46
You have reached the last page of results.This site can display upto 458 results.
Frontiers in Immunology|August 22, 2013
Binding of Soluble Yeast β-Glucan to Human Neutrophils and Monocytes is Complement-DependentNandita Bose, Anissa S H Chan, Faimola Guerrero, et al.
Oncogene|March 11, 2014
MicroRNA-149 targets GIT1 to suppress integrin signaling and breast cancer metastasisS-H Chan, W-C Huang, J-W Chang, et al.
JAMA Oncology|December 29, 2022
Testing for EGFR Variants in Pleural and Pericardial Effusion Cell-Free DNA in Patients With Non-Small Cell Lung CancerKirsty W C Lee, Molly S C Li, Wanxia Gai, et al.
Cancer|December 23, 2014
Preliminary results of trial NPC-0501 evaluating the therapeutic gain by changing from concurrent-adjuvant to induction-concurrent chemoradiotherapy, changing from fluorouracil to capecitabine, and changing from conventional to accelerated radiotherapy fractionation in patients with locoregionally advanced nasopharyngeal carcinomaAnne W M Lee, Roger K C Ngan, Stewart Y Tung, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 8, 2025
Phase 2 trial of imprime and pembrolizumab immunotherapy in metastatic triple negative breast cancer patients who have progressed beyond first line chemotherapyAlison T Stopeck, Maysa Abu-Khalaf, Virginia Borges, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 17, 2019
Immune Pharmacodynamic Responses of the Novel Cancer Immunotherapeutic Imprime PGG in Healthy VolunteersNandita Bose, Nadine R Ottoson, Xiaohong Qiu, et al.
Nature Communications|January 9, 2021
Inhibiting Mycobacterium tuberculosis CoaBC by targeting an allosteric siteVitor Mendes, Simon R Green, Joanna C Evans, et al.
Tissue Antigens|July 6, 2007
Relative predispositional effects of HLA class II DRB1-DQB1 haplotypes and genotypes on type 1 diabetes: a meta-analysisG Thomson, A M Valdes, J A Noble, et al.
Pageof 46